Back to 
ARIEL INVESTMENTS, LLCHAHAE
ARIEL INVESTMENTS, LLCHAHAE1 quarters
Position history for ARIEL INVESTMENTS, LLC's holdings in HAEMONETICS CORP MASS
Yes. Ariel Investments holds 2,060,966 shares of HAE (Haemonetics Corp Mass), worth $154.6M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. HAE is 1.5% of Ariel Investments' reported 13F portfolio.
Current Value
$154.6M
Current Shares
2.1M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of HAE: WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors